))
BioChat #11: The Advantages of ABclonal’s SMab™ Platform
Manage episode 377532876 series 3464173
Sisällön tarjoaa ABclonal Technology. ABclonal Technology tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
BioChat invites ABclonal's chief technology officer, Dr. Hai Wu, to discuss the antibody design and production process using a recombinant monoclonal platform known as SMab™ that has yielded thousands of successful projects and catalog products useful in many fields of bioscience research. Topics include:
- Dr. Wu's love of science and motivation for generating superior antibody products
- The SMab™ platform's advantages and unique versatility in developing antibodies with multiple applications
- The diligent antigen design and antibody validation processes
- Projects and catalog products developed by SMab™ that have accelerated research
To view our webinar and enjoy the antibody data we discussed in this podcast, please visit our website here.
Please bookmark us at www.abclonal.com, read our blog posts here, including an exploration of antibody production strategies, and check out our Doctor Beaker page for fun activities! You can also find all the ways to subscribe to our podcast via our BioChat page, which includes Apple Podcasts and Spotify.
28 jaksoa
Jaa
